Milestone Pharmaceuticals (MIST) Accumulated Expenses: 2021
Historic Accumulated Expenses for Milestone Pharmaceuticals (MIST) over the last 1 years, with Dec 2021 value amounting to $1.5 million.
- Milestone Pharmaceuticals' Accumulated Expenses rose 82.19% to $1.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.9 million, marking a year-over-year increase of 82.19%. This contributed to the annual value of $1.5 million for FY2021, which is N/A change from last year.
- Milestone Pharmaceuticals' Accumulated Expenses amounted to $1.5 million in FY2021.
- Over the past 5 years, Milestone Pharmaceuticals' Accumulated Expenses peaked at $1.5 million during FY2021, and registered a low of $1.5 million during FY2021.
- Its 1-year average for Accumulated Expenses is $1.5 million, with a median of $1.5 million in 2021.